Tsukuba, Japan

Yoshimitsu Yamazaki

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Agency of Industrial Science and Technology. Active years: 1996-2002.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Tsukuba, JP (1996 - 1998)
  • Ibaraki, JP (2002)

Company Filing History:


Years Active: 1996-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yoshimitsu Yamazaki: Innovator in Peptide Technology

Introduction

Yoshimitsu Yamazaki is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of peptide technology, particularly in the regulation of physiological functions.

Latest Patents

Yamazaki holds a patent for a peptide capable of regulating the physiological function of FGF-5. This invention provides a peptide that partially comprises an amino acid sequence of FGF-5 or its alternatively spliced form, FGF-5S. The peptide is designed to control various physiological functions of FGF-5, including the regulation of hair development, cranial nerve system functions, platelet regulation, and the proliferation or differentiation of vascular endothelial cells. He has 1 patent to his name.

Career Highlights

Yamazaki is associated with the Agency of Industrial Science and Technology, where he has been able to apply his innovative ideas in a practical setting. His work has implications for both medical and cosmetic applications, showcasing the versatility of peptide technology.

Collaborations

Yamazaki has collaborated with notable colleagues such as Shuichi Oka and Toru Imamura. Their combined expertise has likely contributed to the advancement of research in their field.

Conclusion

Yoshimitsu Yamazaki is a pioneering inventor whose work in peptide technology has the potential to impact various physiological functions significantly. His contributions continue to shape the landscape of scientific innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…